We Have Better Obesity Medications, but Access Is Lagging
Obesity experts discuss the cost of newer obesity medications (eg, GLP-1 agonists) and access issues, including Ozempic shortages.
Obesity experts discuss the cost of newer obesity medications (eg, GLP-1 agonists) and access issues, including Ozempic shortages.
The company expects ‘pent-up demand’ for the Wegovy (semaglutide) to subside within the next few months
Two more medical societies have come out in support of the AAP’s updated clinical guidelines for obesity treatment in children and adolescents and one opposes it.
Six organizations that focus on the diagnosis and treatment of obesity have released a consensus statement to reduce barriers to care.
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Semaglutide is a glucagon-like peptide-1 receptor agonist.
Unlike people with obesity, lean individuals may not experience health benefits with intentional weight loss.
Nearly half of patients at assisted living facilities showed significant weight loss early during the COVID-19 pandemic.
Panel recommends counseling all women aged 40 to 60 years on healthy eating and physical activity to maintain weight or prevent weight gain.
Effective weight-management resources were delivered to more than 75% of college students with a high BMI within 90 days.